Who has invested in Genuine Biotech?

Pfizer, Verdiva Bio Dev Limited are named among the investors backing Genuine Biotech.

Genuine Biotech Funding: $220M Raised, IPO (2024)

Genuine Biotech funding overview

Genuine Biotech is based in Pingdingshan, Henan, China. Genuine Biotech has raised $220M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is an IPO announced in November 2024. The round record for Genuine Biotech runs through 2024; nothing later has been disclosed. Investors on record include Pfizer, Verdiva Bio Dev Limited. 2 distinct backers are named across the disclosed rounds.

Genuine Biotech at a glance

Total raised: $220M
Latest round: IPO
Latest round date: November 2024
Headquarters: Pingdingshan, Henan, China
Notable investors: Pfizer, Verdiva Bio Dev Limited

Frequently asked about Genuine Biotech funding

How much has Genuine Biotech raised?: Genuine Biotech has raised $220M in total disclosed funding across the rounds on record.
Who has invested in Genuine Biotech?: Pfizer, Verdiva Bio Dev Limited are named among the investors backing Genuine Biotech.
What was the latest Genuine Biotech funding round?: The most recent disclosed round is an IPO, announced in November 2024.
Where is Genuine Biotech based?: Genuine Biotech is based in Pingdingshan, Henan, China.
When did Genuine Biotech last raise?: The last disclosed Genuine Biotech round closed in November 2024 at IPO.

We update the Genuine Biotech record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Pingdingshan and their backers are listed below.

Genuine Biotech Funding: $220M Raised, IPO (2024)

Genuine Biotech funding overview

Genuine Biotech at a glance

Frequently asked about Genuine Biotech funding

Companies related to Genuine Biotech (12)

Browse related funding lists (4)